Daniel Paul Regan Insider Trading $ICPT INTERCEPT PHARMACEUTICALS, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Daniel Paul Regan.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Daniel Paul Regan. Daniel Paul Regan is Chief Commercial Officer in INTERCEPT PHARMACEUTICALS INC ($ICPT).
Daniel Paul Regan in INTERCEPT PHARMACEUTICALS, INC.
Trading Symbol: ICPTIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Daniel Paul Regan: Chief Commercial Officer
Holdings: 1,264 shares
Current Value: $143,552
Latest Transaction: Feb 03 2015
$ICPT Market Capitalization: $2.80B
$ICPT Previous Close: $113.57
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Daniel Paul Regan in INTERCEPT PHARMACEUTICALS, INC.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 03 2015 | ICPT | INTERCEPT PHARMACE ... | Regan Daniel Paul | Chief Commercial Of ... | Option Exercise | M | 37.69 | 9,847 | 371,133 | 92,028 | |
Feb 03 2015 | ICPT | INTERCEPT PHARMACE ... | Regan Daniel Paul | Chief Commercial Of ... | Sell | S | 208.08 | 200 | 41,616 | 1,264 | 1.5 K to 1.3 K (-13.66 %) |
Feb 03 2015 | ICPT | INTERCEPT PHARMACE ... | Regan Daniel Paul | Chief Commercial Of ... | Sell | S | 205.87 | 800 | 164,698 | 1,464 | 2.3 K to 1.5 K (-35.34 %) |
Feb 03 2015 | ICPT | INTERCEPT PHARMACE ... | Regan Daniel Paul | Chief Commercial Of ... | Sell | S | 202.49 | 793 | 160,577 | 2,264 | 3.1 K to 2.3 K (-25.94 %) |
Feb 03 2015 | ICPT | INTERCEPT PHARMACE ... | Regan Daniel Paul | Chief Commercial Of ... | Sell | S | 201.50 | 1,207 | 243,213 | 3,057 | 4.3 K to 3.1 K (-28.31 %) |
Feb 03 2015 | ICPT | INTERCEPT PHARMACE ... | Regan Daniel Paul | Chief Commercial Of ... | Sell | S | 200.07 | 6,847 | 1,369,859 | 4,264 | 11.1 K to 4.3 K (-61.62 %) |
Feb 03 2015 | ICPT | INTERCEPT PHARMACE ... | Regan Daniel Paul | Chief Commercial Of ... | Buy | M | 37.69 | 9,847 | 371,133 | 11,111 | 1.3 K to 11.1 K (+779.03 %) |
Aug 15 2014 | ICPT | INTERCEPT PHARMACE ... | Regan Daniel Paul | Chief Commercial Of ... | Option Exercise | M | 37.69 | 8,124 | 306,194 | 101,875 | |
Aug 15 2014 | ICPT | INTERCEPT PHARMACE ... | Regan Daniel Paul | Chief Commercial Of ... | Sell | S | 346.68 | 224 | 77,656 | 1,410 | 1.6 K to 1.4 K (-13.71 %) |
Aug 15 2014 | ICPT | INTERCEPT PHARMACE ... | Regan Daniel Paul | Chief Commercial Of ... | Sell | S | 344.73 | 500 | 172,366 | 1,634 | 2.1 K to 1.6 K (-23.43 %) |
Aug 15 2014 | ICPT | INTERCEPT PHARMACE ... | Regan Daniel Paul | Chief Commercial Of ... | Sell | S | 343.80 | 800 | 275,039 | 2,134 | 2.9 K to 2.1 K (-27.27 %) |
Aug 15 2014 | ICPT | INTERCEPT PHARMACE ... | Regan Daniel Paul | Chief Commercial Of ... | Sell | S | 342.05 | 300 | 102,614 | 2,934 | 3.2 K to 2.9 K (-9.28 %) |
Aug 15 2014 | ICPT | INTERCEPT PHARMACE ... | Regan Daniel Paul | Chief Commercial Of ... | Sell | S | 341.21 | 300 | 102,362 | 3,234 | 3.5 K to 3.2 K (-8.49 %) |
Aug 15 2014 | ICPT | INTERCEPT PHARMACE ... | Regan Daniel Paul | Chief Commercial Of ... | Sell | S | 337.17 | 100 | 33,717 | 3,534 | 3.6 K to 3.5 K (-2.75 %) |
Aug 15 2014 | ICPT | INTERCEPT PHARMACE ... | Regan Daniel Paul | Chief Commercial Of ... | Sell | S | 336.47 | 200 | 67,293 | 3,634 | 3.8 K to 3.6 K (-5.22 %) |
Aug 15 2014 | ICPT | INTERCEPT PHARMACE ... | Regan Daniel Paul | Chief Commercial Of ... | Sell | S | 335.02 | 100 | 33,502 | 3,834 | 3.9 K to 3.8 K (-2.54 %) |
Aug 15 2014 | ICPT | INTERCEPT PHARMACE ... | Regan Daniel Paul | Chief Commercial Of ... | Sell | S | 331.92 | 200 | 66,384 | 3,934 | 4.1 K to 3.9 K (-4.84 %) |
Aug 15 2014 | ICPT | INTERCEPT PHARMACE ... | Regan Daniel Paul | Chief Commercial Of ... | Sell | S | 330.91 | 206 | 68,167 | 4,134 | 4.3 K to 4.1 K (-4.75 %) |
Aug 15 2014 | ICPT | INTERCEPT PHARMACE ... | Regan Daniel Paul | Chief Commercial Of ... | Sell | S | 329.59 | 594 | 195,777 | 4,340 | 4.9 K to 4.3 K (-12.04 %) |
Aug 15 2014 | ICPT | INTERCEPT PHARMACE ... | Regan Daniel Paul | Chief Commercial Of ... | Sell | S | 327.89 | 300 | 98,366 | 4,934 | 5.2 K to 4.9 K (-5.73 %) |
Aug 15 2014 | ICPT | INTERCEPT PHARMACE ... | Regan Daniel Paul | Chief Commercial Of ... | Sell | S | 326.03 | 100 | 32,603 | 5,234 | 5.3 K to 5.2 K (-1.87 %) |
Aug 15 2014 | ICPT | INTERCEPT PHARMACE ... | Regan Daniel Paul | Chief Commercial Of ... | Sell | S | 322.92 | 100 | 32,292 | 5,334 | 5.4 K to 5.3 K (-1.84 %) |
Aug 15 2014 | ICPT | INTERCEPT PHARMACE ... | Regan Daniel Paul | Chief Commercial Of ... | Sell | S | 321.44 | 200 | 64,288 | 5,434 | 5.6 K to 5.4 K (-3.55 %) |
Aug 15 2014 | ICPT | INTERCEPT PHARMACE ... | Regan Daniel Paul | Chief Commercial Of ... | Sell | S | 319.47 | 400 | 127,787 | 5,634 | 6 K to 5.6 K (-6.63 %) |
Aug 15 2014 | ICPT | INTERCEPT PHARMACE ... | Regan Daniel Paul | Chief Commercial Of ... | Sell | S | 317.71 | 400 | 127,082 | 6,034 | 6.4 K to 6 K (-6.22 %) |
Aug 15 2014 | ICPT | INTERCEPT PHARMACE ... | Regan Daniel Paul | Chief Commercial Of ... | Sell | S | 316.62 | 200 | 63,324 | 6,434 | 6.6 K to 6.4 K (-3.01 %) |
Aug 15 2014 | ICPT | INTERCEPT PHARMACE ... | Regan Daniel Paul | Chief Commercial Of ... | Sell | S | 314.93 | 600 | 188,955 | 6,634 | 7.2 K to 6.6 K (-8.29 %) |
Aug 15 2014 | ICPT | INTERCEPT PHARMACE ... | Regan Daniel Paul | Chief Commercial Of ... | Sell | S | 313.84 | 800 | 251,072 | 7,234 | 8 K to 7.2 K (-9.96 %) |
Aug 15 2014 | ICPT | INTERCEPT PHARMACE ... | Regan Daniel Paul | Chief Commercial Of ... | Sell | S | 312.78 | 200 | 62,555 | 8,034 | 8.2 K to 8 K (-2.43 %) |
Aug 15 2014 | ICPT | INTERCEPT PHARMACE ... | Regan Daniel Paul | Chief Commercial Of ... | Sell | S | 311.89 | 500 | 155,943 | 8,234 | 8.7 K to 8.2 K (-5.72 %) |
Aug 15 2014 | ICPT | INTERCEPT PHARMACE ... | Regan Daniel Paul | Chief Commercial Of ... | Sell | S | 310.11 | 500 | 155,052 | 8,734 | 9.2 K to 8.7 K (-5.41 %) |
Aug 15 2014 | ICPT | INTERCEPT PHARMACE ... | Regan Daniel Paul | Chief Commercial Of ... | Sell | S | 306.91 | 100 | 30,691 | 9,234 | 9.3 K to 9.2 K (-1.07 %) |
Aug 15 2014 | ICPT | INTERCEPT PHARMACE ... | Regan Daniel Paul | Chief Commercial Of ... | Sell | S | 305.39 | 200 | 61,077 | 9,334 | 9.5 K to 9.3 K (-2.10 %) |
Aug 15 2014 | ICPT | INTERCEPT PHARMACE ... | Regan Daniel Paul | Chief Commercial Of ... | Buy | M | 37.69 | 8,124 | 306,194 | 9,534 | 1.4 K to 9.5 K (+576.17 %) |
Jul 08 2014 | ICPT | INTERCEPT PHARMACE ... | Regan Daniel Paul | Chief Commercial Of ... | Option Exercise | M | 37.69 | 1 | 38 | 109,999 | |
Jul 08 2014 | ICPT | INTERCEPT PHARMACE ... | Regan Daniel Paul | Chief Commercial Of ... | Sell | S | 250.00 | 1 | 250 | 1,410 | 1.4 K to 1.4 K (-0.07 %) |
Jul 08 2014 | ICPT | INTERCEPT PHARMACE ... | Regan Daniel Paul | Chief Commercial Of ... | Buy | M | 37.69 | 1 | 38 | 1,411 | 1.4 K to 1.4 K (+0.07 %) |
Page: 1